AIM
RPTP

Alambic Investment Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Alambic Investment Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,000
Closed -$90K – 643
2016
Q3 		$90K Sell
10,000
-100
-1% -$711 0.02% 483
2016
Q2 		$54K Buy
+10,100
New +$51.8K 0.01% 523
2016
Q1 		– Sell
-14,800
Closed -$77K – 574
2015
Q4 		$77K Buy
+14,800
New +$85.9K 0.05% 339

Alambic Investment Management's RPTP Position: Q4 2016 in Review

Alambic Investment Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 10,000 shares — an estimated $90K sold.

Alambic Investment Management first reported a position in RPTP in Q4 2015 and held it in 3 quarters. The position peaked at $90K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Alambic Investment Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Alambic Investment Management sold 10,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $90K.
  • Alambic Investment Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2015 and held it in 3 quarters.
  • Alambic Investment Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $90K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Alambic Investment Management's 13F filing for Q4 2016, filed 3 Feb 2017.